BioNTech SE (BNTX) Event May 12, 2022, 21:18 UTC (10% Negative) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 4:53 p.m. 🌍 BioNTech SE (BNTX) - Form 6-K Filing Filing Date: 2022-05-12 Accepted: 2022-05-12 17:18:38 Event Type: Clinical Trial Update Event Details: 1 biontechq12022earningspr 1st Quarter 2022 Financial Results Corporate Update May 9, 2022 Exhibit 99. 1 2 biontechq12022earningspr. 💼 Business Developments: ✅ Partnership/Collaboration❌ Acquisition Activity: Not reported❌ Licensing Agreement: Not reported✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Phone: 800-438-1985Email: medinfo@biontech.de
🌍 BioNTech SE (BNTX) - Form 6-K Filing
Filing Date: 2022-05-12
Accepted: 2022-05-12 17:18:38
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: